Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant.

AUTOR(ES)

Prinarakis, E E

RESUMO

An inhibitor-resistant beta-lactamase (SHV-10), derived from an SHV-5 variant (SHV-9), was found in an Escherichia coli clinical isolate. In SHV-10, Ser-130 was replaced by Gly. The enzyme partially retained its ability to hydrolyze penicillins, but its activity against cephalosporins was drastically reduced. A Ser-130-->Gly mutant of the prototype SHV-5, obtained by site-directed mutagenesis, had properties similar to those of SHV-10.

Documentos Relacionados

• Characterization of an inhibitor-resistant TEM (IRT) beta-lactamase in a novel strain of Klebsiella pneumoniae.
• Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid.
• Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
• Inhibitor-Resistant OXY-2-Derived β-Lactamase Produced by Klebsiella oxytoca
• SHV-49, a Novel Inhibitor-Resistant β-Lactamase in a Clinical Isolate of Klebsiella pneumoniae